127 related articles for article (PubMed ID: 38575184)
21. The combined immunodetection of AP-2alpha and YY1 transcription factors is associated with ERBB2 gene overexpression in primary breast tumors.
Allouche A; Nolens G; Tancredi A; Delacroix L; Mardaga J; Fridman V; Winkler R; Boniver J; Delvenne P; Begon DY
Breast Cancer Res; 2008; 10(1):R9. PubMed ID: 18218085
[TBL] [Abstract][Full Text] [Related]
22. YY1 Is an Inducer of Cancer Metastasis.
Wang W; Li D; Sui G
Crit Rev Oncog; 2017; 22(1-2):1-11. PubMed ID: 29604932
[TBL] [Abstract][Full Text] [Related]
23. CRTAC1 (Cartilage acidic protein 1) inhibits cell proliferation, migration, invasion and epithelial-mesenchymal transition (EMT) process in bladder cancer by downregulating Yin Yang 1 (YY1) to inactivate the TGF-β pathway.
Yang J; Fan L; Liao X; Cui G; Hu H
Bioengineered; 2021 Dec; 12(2):9377-9389. PubMed ID: 34818994
[TBL] [Abstract][Full Text] [Related]
24. YY1-Induced Transcriptional Activation of FAM111B Contributes to the Malignancy of Breast Cancer.
Li W; Hu S; Han Z; Jiang X
Clin Breast Cancer; 2022 Jun; 22(4):e417-e425. PubMed ID: 34802969
[TBL] [Abstract][Full Text] [Related]
25. RING1 and YY1 binding protein suppresses breast cancer growth and metastasis.
Zhou H; Li J; Zhang Z; Ye R; Shao N; Cheang T; Wang S
Int J Oncol; 2016 Dec; 49(6):2442-2452. PubMed ID: 27748911
[TBL] [Abstract][Full Text] [Related]
26. CircAGFG1 drives metastasis and stemness in colorectal cancer by modulating YY1/CTNNB1.
Zhang L; Dong X; Yan B; Yu W; Shan L
Cell Death Dis; 2020 Jul; 11(7):542. PubMed ID: 32681092
[TBL] [Abstract][Full Text] [Related]
27. The DDX6/KIFC1 signaling axis, as regulated by YY1, contributes to the malignant behavior of pancreatic cancer.
Deng X; Liu Z; Wang B; Ma J; Meng X
FASEB J; 2024 Apr; 38(7):e23581. PubMed ID: 38551642
[TBL] [Abstract][Full Text] [Related]
28. Expression of UGT2B7, a UDP-glucuronosyltransferase implicated in the metabolism of 4-hydroxyestrone and all-trans retinoic acid, in normal human breast parenchyma and in invasive and in situ breast cancers.
Gestl SA; Green MD; Shearer DA; Frauenhoffer E; Tephly TR; Weisz J
Am J Pathol; 2002 Apr; 160(4):1467-79. PubMed ID: 11943730
[TBL] [Abstract][Full Text] [Related]
29. Yin Yang 1 positively regulates BRCA1 and inhibits mammary cancer formation.
Lee MH; Lahusen T; Wang RH; Xiao C; Xu X; Hwang YS; He WW; Shi Y; Deng CX
Oncogene; 2012 Jan; 31(1):116-27. PubMed ID: 21666725
[TBL] [Abstract][Full Text] [Related]
30. The Yin and Yang of YY1 in tumor growth and suppression.
Khachigian LM
Int J Cancer; 2018 Aug; 143(3):460-465. PubMed ID: 29322514
[TBL] [Abstract][Full Text] [Related]
31. microRNA-7 is a novel inhibitor of YY1 contributing to colorectal tumorigenesis.
Zhang N; Li X; Wu CW; Dong Y; Cai M; Mok MT; Wang H; Chen J; Ng SS; Chen M; Sung JJ; Yu J
Oncogene; 2013 Oct; 32(42):5078-88. PubMed ID: 23208495
[TBL] [Abstract][Full Text] [Related]
32. Yin Yang 1 cooperates with activator protein 2 to stimulate ERBB2 gene expression in mammary cancer cells.
Begon DY; Delacroix L; Vernimmen D; Jackers P; Winkler R
J Biol Chem; 2005 Jul; 280(26):24428-34. PubMed ID: 15870067
[TBL] [Abstract][Full Text] [Related]
33. YY1 regulates melanoma tumorigenesis through a miR-9 ~ RYBP axis.
Zhao G; Li Q; Wang A; Jiao J
J Exp Clin Cancer Res; 2015 Jun; 34(1):66. PubMed ID: 26104682
[TBL] [Abstract][Full Text] [Related]
34. miR-34a-5p suppresses the invasion and metastasis of liver cancer by targeting the transcription factor YY1 to mediate MYCT1 upregulation.
Xu XP; Peng XQ; Yin XM; Liu Y; Shi ZY
Acta Histochem; 2020 Sep; 122(6):151576. PubMed ID: 32778238
[TBL] [Abstract][Full Text] [Related]
35. Resveratrol represses estrogen-induced mammary carcinogenesis through NRF2-UGT1A8-estrogen metabolic axis activation.
Zhou X; Zhao Y; Wang J; Wang X; Chen C; Yin D; Zhao F; Yin J; Guo M; Zhang L; Du L; Zhang B; Yin X
Biochem Pharmacol; 2018 Sep; 155():252-263. PubMed ID: 30009768
[TBL] [Abstract][Full Text] [Related]
36. Circular RNA circ_0001588 sponges miR-211-5p to facilitate the progression of glioblastoma via up-regulating YY1 expression.
Wang Q; Zheng D; Li Y; Zhang Y; Sui R; Chen Y; Liang H; Shi J; Pan R; Xu X; Sun D
J Gene Med; 2021 Oct; 23(10):e3371. PubMed ID: 34105224
[TBL] [Abstract][Full Text] [Related]
37. YY1-mediated long non-coding RNA Kcnq1ot1 promotes the tumor progression by regulating PTEN via DNMT1 in triple negative breast cancer.
Shen B; Li Y; Ye Q; Qin Y
Cancer Gene Ther; 2021 Nov; 28(10-11):1099-1112. PubMed ID: 33323961
[TBL] [Abstract][Full Text] [Related]
38. Homeostasis Imbalance of YY2 and YY1 Promotes Tumor Growth by Manipulating Ferroptosis.
Li Y; Li J; Li Z; Wei M; Zhao H; Miyagishi M; Wu S; Kasim V
Adv Sci (Weinh); 2022 May; 9(13):e2104836. PubMed ID: 35246964
[TBL] [Abstract][Full Text] [Related]
39. Dysregulated Kras/YY1/ZNF322A/Shh transcriptional axis enhances neo-angiogenesis to promote lung cancer progression.
Lin CC; Kuo IY; Wu LT; Kuan WH; Liao SY; Jen J; Yang YE; Tang CW; Chen YR; Wang YC
Theranostics; 2020; 10(22):10001-10015. PubMed ID: 32929330
[TBL] [Abstract][Full Text] [Related]
40. miR-5590-3p-YY1 feedback loop promotes the proliferation and migration of triple-negative breast cancer cells.
Liang F; Fu X; Wang L
J Cell Biochem; 2019 Oct; 120(10):18415-18424. PubMed ID: 31190375
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
